161 related articles for article (PubMed ID: 10886273)
1. Q-switched ruby laser treatment for postsclerotherapy hyperpigmentation.
Tafazzoli A; Rostan EF; Goldman MP
Dermatol Surg; 2000 Jul; 26(7):653-6. PubMed ID: 10886273
[TBL] [Abstract][Full Text] [Related]
2. Postsclerotherapy hyperpigmentation. Treatment with a flashlamp-excited pulsed dye laser.
Goldman MP
J Dermatol Surg Oncol; 1992 May; 18(5):417-22. PubMed ID: 1607465
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Q-switched alexandrite, Nd:YAG, and ruby lasers in treating blue-black tattoos.
Leuenberger ML; Mulas MW; Hata TR; Goldman MP; Fitzpatrick RE; Grevelink JM
Dermatol Surg; 1999 Jan; 25(1):10-4. PubMed ID: 9935085
[TBL] [Abstract][Full Text] [Related]
4. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser.
Taylor CR; Anderson RR
J Dermatol Surg Oncol; 1994 Sep; 20(9):592-7. PubMed ID: 8089359
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate.
Lopez L; Dilley RB; Henriquez JA
Dermatol Surg; 2001 Sep; 27(9):795-8. PubMed ID: 11553167
[TBL] [Abstract][Full Text] [Related]
6. Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial.
Scultetus AH; Villavicencio JL; Kao TC; Gillespie DL; Ketron GD; Iafrati MD; Pikoulis E; Eifert S
J Vasc Surg; 2003 Nov; 38(5):896-903. PubMed ID: 14603191
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
[TBL] [Abstract][Full Text] [Related]
8. Benign pigmented lesions of the skin. Treatment with the Q-switched ruby laser.
Goldberg DJ
J Dermatol Surg Oncol; 1993 Apr; 19(4):376-9. PubMed ID: 8478478
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians.
Momosawa A; Kurita M; Ozaki M; Miyamoto S; Kobayashi Y; Ban I; Harii K
Plast Reconstr Surg; 2008 Jan; 121(1):282-288. PubMed ID: 18176232
[TBL] [Abstract][Full Text] [Related]
10. Q-switched ruby laser in the treatment of nevus of Ota.
Yang HY; Lee CW; Ro YS; Yu HJ; Kim YT; Kim JH; Kim JH
J Korean Med Sci; 1996 Apr; 11(2):165-70. PubMed ID: 8835765
[TBL] [Abstract][Full Text] [Related]
11. Q-switched ruby laser is safe and effective in treating primary gingival hyperpigmentation.
Noyman Y; Kornowski Y; Slodownik D; Lapidoth M; Levi A
J Cosmet Dermatol; 2023 Sep; 22(9):2481-2484. PubMed ID: 37143439
[TBL] [Abstract][Full Text] [Related]
12. Postsclerotherapy pigmentation. Is serum ferritin level an accurate indicator?
Scott C; Seiger E
Dermatol Surg; 1997 Apr; 23(4):281-2; discussion 283. PubMed ID: 9149795
[TBL] [Abstract][Full Text] [Related]
13. Early serial Q-switched ruby laser therapy for medium-sized to giant congenital melanocytic naevi.
Kishi K; Okabe K; Ninomiya R; Konno E; Hattori N; Katsube K; Imanish N; Nakajima H; Nakajima T
Br J Dermatol; 2009 Aug; 161(2):345-52. PubMed ID: 19438478
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment.
Goldman MP; Sadick NS; Weiss RA
Dermatol Surg; 1995 Jan; 21(1):19-29; quiz 31-2. PubMed ID: 7600016
[TBL] [Abstract][Full Text] [Related]
15. Minocycline-induced hyperpigmentation of the tongue: successful treatment with the Q-switched ruby laser.
Friedman IS; Shelton RM; Phelps RG
Dermatol Surg; 2002 Mar; 28(3):205-9. PubMed ID: 11896769
[TBL] [Abstract][Full Text] [Related]
16. Postsclerotherapy hyperpigmentation. The role of serum ferritin levels and the effectiveness of treatment with the copper vapor laser.
Thibault P; Wlodarczyk J
J Dermatol Surg Oncol; 1992 Jan; 18(1):47-52. PubMed ID: 1740567
[TBL] [Abstract][Full Text] [Related]
17. Postsclerotherapy hyperpigmentations. Chromated glycerin as a screen for patients at risk (a retrospective study).
Georgiev M
J Dermatol Surg Oncol; 1993 Jul; 19(7):649-52. PubMed ID: 8349903
[TBL] [Abstract][Full Text] [Related]
18. Treatment of nonmelanotic hyperpigmentation with the Q-switched ruby laser.
Becker-Wegerich PM; Kuhn A; Malek L; Lehmann P; Megahed M; Ruzicka T
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):272-4. PubMed ID: 10906650
[TBL] [Abstract][Full Text] [Related]
19. Treatment of benign pigmented epidermal lesions by Q-switched ruby laser.
Taylor CR; Anderson RR
Int J Dermatol; 1993 Dec; 32(12):908-12. PubMed ID: 8125702
[TBL] [Abstract][Full Text] [Related]
20. Laser therapy of pigmented lesions: pro and contra.
Bukvić Mokos Z; Lipozenčić J; Ceović R; Stulhofer Buzina D; Kostović K
Acta Dermatovenerol Croat; 2010; 18(3):185-9. PubMed ID: 20887701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
